H.W. Reesink

Statistics

Publications

Citations

559

H-Index

Active since

2006

Affiliations

Amsterdam UMC Location University of Amsterdam(Current)

Erasmus MC

Medical University of Białystok

University of Amsterdam

Hôpital Beaujon

H.W. Reesink is an author at Amsterdam UMC Location University of Amsterdam specializing in viral hepatitis, viral hepatitis treatment, and antiviral therapy.

Publications per year

2006–2018

Publications

Combination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B

Patrick Marcellin, Sang Hoon Ahn, Xiaoli Ma et al. · Gastroenterology · 2015 · 338 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Randomised clinical trial: anti-viral activity of ANA773, an oral inducer of endogenous interferons acting via TLR7, in chronic HCV

Jean‐François Bergmann, Joep de Bruijne, Daphne M. Hotho et al. · Alimentary Pharmacology & Therapeutics · 2011 · 52 citations

Medicine, Infectious Diseases, Pharmacology +17

Validation of a sensitive and specific real‐time PCR for detection and quantitation of hepatitis B virus covalently closed circular DNA in plasma of chronic hepatitis B patients

R. Bart Takkenberg, Hans L. Zaaijer, Richard Molenkamp et al. · Journal of Medical Virology · 2009 · 35 citations

Medicine, Infectious Diseases, Molecular Biology +17

737 Initial results of a 14-day study of the hepatitis C virus inhibitor protease VX-950, in combination with peginterferon-alpha-2a

H.W. Reesink, N. Forestiere, Christine J. Weegink et al. · Journal of Hepatology · 2006 · 25 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +12

11 OPERA-1 TRIAL: INTERIM ANALYSIS OF SAFETY AND ANTIVIRAL ACTIVITY OF TMC435 IN TREATMENT-NAIVE GENOTYPE 1 HCV PATIENTS

M.P. Manns, H.W. Reesink, Christophe Moreno et al. · Journal of Hepatology · 2009 · 25 citations

Medicine, Infectious Diseases, Pharmacology +13

1–5 of 11